Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents

Annals of Surgical Oncology

Volumn 19, Issue 12, 2012, Pages 3745-3752

  Mita, Kazuhito ^a   Ito, Hideto ^a   Murabayashi, Ryo ^a   Sueyoshi, Kouichirou ^a   Asakawa, Hideki ^a   Nabetani, Masashi ^a   Kamasako, Akira ^a   Koizumi, Kazuya ^a   Hayashi, Takashi ^a  

^a NEW TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; WARFARIN;

ABDOMINAL ABSCESS; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; ILEUS; LUNG EMBOLISM; MALE; MEDICAL RECORD REVIEW; PANCREAS FISTULA; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; RISK FACTOR; STOMACH CANCER; SURGICAL INFECTION; SURGICAL PATIENT; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HEMORRHAGE; HUMANS; JAPAN; MALE; NEOPLASM STAGING; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; THROMBOEMBOLISM;

EID: 84868150313     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2500-6     Document Type: Article

References (27)

1. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy: Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767-73. (Pubitemid 41079893)
2. Degiuli M, Sasako M, Ponti A, et al. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010; 97:643-9.
3. Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92: 1099-102. (Pubitemid 41284874)
4. Kim MC, Kim W, Kim HH, et al. Risk factors associated with complication following laparoscopy-assisted gastrectomy for gastric cancer: a large-scale Korean multicenter study. Ann Surg Oncol. 2008;15:2692-700.
5. Jeong O, Park YK, Ryu SY, et al. Predisposing factors and management of postoperative bleeding after radical gastrectomy for gastric carcinoma. Surg Today. 2011;41:363-8.
6. Thachil J, Gatt A, Martlew V. Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg. 2008;95:1437-48.
7. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edn. Gastric Cancer. 1998;1:10-24.
8. Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164:1319-26. (Pubitemid 38828883)
9. Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost. 2007;5:2211-8. (Pubitemid 47617873)
10. Ansell JE. The perioperative management of warfarin therapy. Arch Intern Med. 2003;163:881-3. (Pubitemid 36522736)
11. Chassot PG, Delabays A, Spahn DR. Perioperative use of antiplatelet drugs. Best Pract Res Clin Anaesthesiol. 2007;21:241-56.
12. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-47.
13. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2007;116:e418-99.
14. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;336:1506-11.
15. Varkarakis IM, Rais-Bahrami S, Allaf ME, et al. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy. J Urol. 2005;174:1020-3. (Pubitemid 41140667)
16. Ercan M, Bostanci EB, Ozer I. Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy. Langenbecks Arch Surg. 2010;395:247-53.
17. Iqbal CW, Cima RR, Pemberton JH. Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations. J Gastrointest Surg. 2011;15:2016-22.
18. Mourelo R, Kaidar-Person O, Fajnwaks P, et al. Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy. Obes Surg. 2008;18: 167-70.
19. Jeong O, Ryu SY, Park YK, The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery. Ann Surg Oncol. 2010;17:2363-9.
20. Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with itscontinuation: review and meta-analysis. J Intern Med. 2005;257: 399-414. (Pubitemid 40604544)
21. Eikelboom JW, Hirsch J. Bleeding and management of bleeding. Eur Heart J. 2006;8:G38-45. (Pubitemid 44526985)
22. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288-94. (Pubitemid 30206904)
23. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol. 2007;49:122-4. (Pubitemid 46026891)
24. Gershlick AH, Richardson G. Drug eluting stents. BMJ. 2006; 333:1233-4. (Pubitemid 46043104)
25. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol. 2005;45:456-9. (Pubitemid 40186800)
26. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803-9. (Pubitemid 44305292)
27. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference onAntithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S-400S. (Pubitemid 39302602)